Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001576280-23-000089
Filing Date
2023-06-13
Accepted
2023-06-13 17:46:01
Documents
1
Period of Report
2023-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1686692745.html 4  
1 FORM 4 wk-form4_1686692745.xml 4 6449
  Complete submission text file 0001576280-23-000089.txt   7886
Mailing Address 3100 HANOVER STREET PALO ALTO CA 94304
Business Address 3100 HANOVER STREET PALO ALTO CA 94304 855-698-8887
Guardant Health, Inc. (Issuer) CIK: 0001576280 (see all company filings)

EIN.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories

Mailing Address C/O ACELRX PHARMACEUTICALS, INC. 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address
Saia John G. (Reporting) CIK: 0001737840 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38683 | Film No.: 231012365